Sree Gokulam Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 65.05%
(FY 2020)
- Profit 189.71%
(FY 2020)
- Ebitda 300.98%
(FY 2020)
- Net Worth 240.84%
(FY 2020)
- Total Assets 89.75%
(FY 2020)
About Sree Gokulam Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manojan Kandiyil and Thoolicheendavida Pradeeshkumar serve as directors at the Company.
- CIN/LLPIN
U51397KL2012PTC031392
- Company No.
031392
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2012
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sree Gokulam Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manojan Kandiyil  | Director | 16-Jun-2012 | Current |
| Thoolicheendavida Pradeeshkumar | Additional Director | 14-Dec-2023 | Current |
Financial Performance of Sree Gokulam Pharma.
Sree Gokulam Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 65.05% increase. The company also saw a substantial improvement in profitability, with a 189.71% increase in profit. The company's net worth Soared by an impressive increase of 240.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sree Gokulam Pharma?
In 2018, Sree Gokulam Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sree Gokulam Housing Company Private LimitedActive 17 years 11 monthsThoolicheendavida Pradeeshkumar is a mutual person
Sree Gokulam Chit & Finance Co Private LimitedActive 49 years 3 monthsThoolicheendavida Pradeeshkumar is a mutual person
- Sree Gokulam Health International Private LimitedActive 11 months 16 days
Manojan Kandiyil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sree Gokulam Pharma?
Unlock and access historical data on people associated with Sree Gokulam Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sree Gokulam Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sree Gokulam Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
